PRDS

Pardes Biosciences, Inc. Common Stock
PRDS

Overview Fund Activity
Delisted

PRDS was delisted on the 30th of August, 2023.

Back to rankings

69 hedge funds and large institutions have $144M invested in Pardes Biosciences, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 9 closing their positions.

Holders
69
Holders Change
+12
Holders Change %
+21.05%
% of All Funds
1.17%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.08%
New
21
Increased
16
Reduced
20
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VS
1
VK Services
California
$18.9M
2
Goldman Sachs
2
Goldman Sachs
New York
$13.1M
3
BlackRock
3
BlackRock
New York
$4.93M
4
LCM
4
Lynx1 Capital Management
Puerto Rico
$6.69M
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$1.51M

Top Sellers

1
FLSM
1
Frazier Life Sciences Management
California
$2.6M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$0
3
ACM
3
Altium Capital Management
New York
$0
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$3.95M
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
OCM
76
Ovata Capital Management
Hong Kong
– – -500 Closed
CFGS
77
Concourse Financial Group Securities
Alabama
– – – –
CS
78
Credit Suisse
Switzerland
$0 14 +14 New
Fidelity Investments
79
Fidelity Investments
Massachusetts
$0 138 +138 New
1 2 3
4